| Identification | More | [Name]
4,5-DIBROMO-O-XYLENE | [CAS]
24932-48-7 | [Synonyms]
1,2-DIBROMO-4,5-DIMETHYLBENZENE
4,5-DIBROMO-1,2-DIMETHYLBENZENE
4,5-DIBROMO-O-XYLENE
1,2-Dibromo-4,5-dimethylbenzene 98+% | [Molecular Formula]
C8H8Br2 | [MDL Number]
MFCD00082743 | [Molecular Weight]
263.96 | [MOL File]
24932-48-7.mol |
| Chemical Properties | Back Directory | [Melting point ]
85-89 °C (lit.) | [Boiling point ]
278 °C | [density ]
1.7485 (rough estimate) | [refractive index ]
1.6146 (estimate) | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Pale Yellow | [BRN ]
2206183 | [InChIKey]
BCIDDURGCAHERU-UHFFFAOYSA-N | [CAS DataBase Reference]
24932-48-7(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37:Wear suitable protective clothing and gloves . | [WGK Germany ]
3
| [HazardClass ]
IRRITANT | [HS Code ]
29039990 |
| Hazard Information | Back Directory | [Chemical Properties]
White solid | [Uses]
1,2-Dibromo-4,5-dimethylbenzene is used as a reagent in the synthesis of Thalidomide (T338850); an inhibitor of FGF-induced angiogenesis and replication of human immunodeficiency virus type 1. Also a teratogenic sedative and immunomodulatory agent used primarily in combination with dexamethasone to treat multiple myeloma. | [General Description]
1,2-Dibromo-4,5-dimethylbenzene can be synthesized via bromination of o-xylene. |
|
|